U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
148951148951Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)CompletedHas ResultsPostherpetic NeuralgiaDrug: Retigabine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00612105
148952148952Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A Sequential Scan ProtocolRecruitingNo Results AvailableCoronary DiseaseRadiation: Spiral image acquisition|Radiation: sequential image acquisitionhttps://ClinicalTrials.gov/show/NCT00612092
148953148953The Effect of Sertindole on Sensory Gating and Cognition in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Sertindole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00612079
148954148954Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)TerminatedNo Results AvailableCushing's DiseaseDrug: rosiglitazone maleate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00612066
148955148955Italian Registry on Unprotected Left MainRecruitingNo Results AvailableCardiovascular Disease|Coronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT00612053
148956148956Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1Drug: insulin degludec|Drug: insulin degludec|Drug: insulin glargine|Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT00612040
148957148957Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care ConditionsCompletedNo Results AvailableGastrointestinal Diseaseshttps://ClinicalTrials.gov/show/NCT00612027
148958148958Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic GastroparesisCompletedNo Results AvailableGastroparesis|Diabetes MellitusDrug: 5% dextrose in water|Drug: TZP-101|Drug: TZP-101|Drug: TZP-101|Drug: TZP-101|Drug: TZP-101https://ClinicalTrials.gov/show/NCT00612014
148959148959Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsBiological: glioma-associated antigen peptide-pulsed autologous dendritic cell vaccinehttps://ClinicalTrials.gov/show/NCT00612001
148960148960Self-Managed Walking Improves FunctionCompletedNo Results AvailablePeripheral Arterial Disease|Diabetes MellitusBehavioral: Self-managed walking|Other: Control grouphttps://ClinicalTrials.gov/show/NCT00611988
148961148961Effect of Antidepressants on Sex Hormone Levels and Sexual FunctioningCompletedNo Results AvailableHealthyDrug: Fluoxetine|Drug: Bupropionhttps://ClinicalTrials.gov/show/NCT00611975
148962148962Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNo Results AvailableNeoplasms, Germ Cell and EmbryonalDrug: Oxaliplatin, Paclitaxelhttps://ClinicalTrials.gov/show/NCT00611962
148963148963Comparison of 2 Vials of Components of a Synthetic Geranium OilCompletedNo Results AvailableNeuropathic PainOther: Geranium oilhttps://ClinicalTrials.gov/show/NCT00611949
148964148964Effects of Atomoxetine Treatment in HumansCompletedNo Results AvailableStressDrug: Placebo|Drug: Atomoxetinehttps://ClinicalTrials.gov/show/NCT00611936
148965148965Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric DisorderCompletedNo Results AvailablePremenstrual SyndromeDrug: Flutamide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00611923
148966148966Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft LesionsCompletedNo Results AvailableArteriosclerosis of Arterial Coronary Artery Bypass GraftDevice: sirolimus-eluting stent|Device: paclitaxel-eluting stent|Device: biodegradable-polymer-based sirolimus-eluting stent|Device: bare metal stentshttps://ClinicalTrials.gov/show/NCT00611910
148967148967N-acetylcysteine and NMDA Antagonist InteractionsCompletedHas ResultsCognitive DysfunctionDrug: N-acetylcysteine and ketamine|Drug: placebo and ketaminehttps://ClinicalTrials.gov/show/NCT00611897
148968148968Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin glargine|Drug: insulin degludec|Drug: insulin degludec|Drug: insulin degludec|Drug: metforminhttps://ClinicalTrials.gov/show/NCT00611884
148969148969The Use of Propranolol to Block Memory Reconsolidation in PTSDTerminatedNo Results AvailablePosttraumatic Stress DisordersDrug: Propranolol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00611871
148970148970Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerTerminatedNo Results AvailableRectal CancerDrug: Cetuximab|Drug: 5-Fluorouracil|Radiation: External Beam Pelvis Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00611858
148971148971Aprotinin US Special Access ProtocolNo longer availableNo Results AvailablePostoperative HemorrhageDrug: Aprotinin (Trasylol, BAYA0128)https://ClinicalTrials.gov/show/NCT00611845
148972148972Evaluation of a Video-Based Media Series to Promote Effective ParentingCompletedNo Results AvailableChildhood Disruptive Behavior ProblemsBehavioral: Triple P Media Series -- Standard "Information-Only" version|Behavioral: Triple P Media Series -- Enhanced "Behavior Activation" versionhttps://ClinicalTrials.gov/show/NCT00611832
148973148973Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCVActive, not recruitingNo Results AvailableChronic Hepatitis C|Co-Infection HIV-HCVDrug: Peg interferon + Ribavirin|Drug: Peg interferon + Ribavirinhttps://ClinicalTrials.gov/show/NCT00611819
148974148974Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of SchizophreniaCompletedHas ResultsSchizophreniaDietary Supplement: Folic Acid|Dietary Supplement: B12|Other: Placebohttps://ClinicalTrials.gov/show/NCT00611806
148975148975PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced MalignanciesCompletedNo Results AvailableRefractory Malignancy|Advanced MalignanciesDrug: PTK787/ZK222584 and Bevacizumabhttps://ClinicalTrials.gov/show/NCT00611793
148976148976Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV ProtocolRecruitingNo Results AvailableCoronary DiseaseRadiation: tube voltage|Radiation: tube voltagehttps://ClinicalTrials.gov/show/NCT00611780
148977148977GABA Mechanisms Underlying the Vulnerability to Alcohol DependenceCompletedNo Results AvailableAlcoholismDrug: Thiopental|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00611767
148978148978Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNo Results AvailableHead and Neck CancerDrug: Oxaliplatin, 5-FUhttps://ClinicalTrials.gov/show/NCT00611754
148979148979The Effect of Plasma Osmolality on Brain GlutamateCompletedNo Results AvailableSchizophreniaDrug: furosemide, Na supplementshttps://ClinicalTrials.gov/show/NCT00611741
148980148980Ph I SU011248 + Irinotecan in Treatment of Pts w MGCompletedNo Results AvailableGlioblastomaDrug: SU011248 & Irinotecanhttps://ClinicalTrials.gov/show/NCT00611728

* Görseller ve İçerik tekif hakkına sahip olabilir